Shoulder Innovations, Inc. (SI): Cost of Revenue
$11.12M
Year ended 2025-12-31
$13.61M
Trailing 12 months to 2026-06-30
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $11.12M | +52.6% | 2026-03-10, From 2025-01-01 |
| 2024-12-31 | $7.28M | n/a | 2026-03-10, From 2024-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| Shoulder Innovations, Inc. (SI) | 2025-12-31 | $11.12M | +52.6% |
| TriSalus Life Sciences, Inc. (TLSI) | 2025-12-31 | $6.96M | +69.8% |
| Carlsmed, Inc. (CARL) | 2025-12-31 | $12.47M | +75.2% |
| SANUWAVE Health, Inc. (SNWV) | 2025-12-31 | $10.08M | +24.7% |
| SS Innovations International, Inc. (SSII) | 2025-12-31 | $22.94M | +88.1% |
| Apyx Medical Corp (APYX) | 2025-12-31 | $19.80M | +5.6% |
| KORU Medical Systems, Inc. (KRMD) | 2025-12-31 | $15.52M | +26.1% |
| CVRx, Inc. (CVRX) | 2025-12-31 | $8.31M | -0.3% |
| Interpace Biosciences, Inc. (IDXG) | 2025-12-31 | $14.60M | -14.1% |
Compare SI, TLSI, CARL, SNWV side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗